NRX Pharmaceuticals Inc. share price logo

NRX Pharmaceuticals Inc.

NASDAQ: NRXP

$4.18

-0.09

(-2.11%)

as on

NRX Pharmaceuticals Inc. Stock Performance

as on July 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.12
    $4.39
    downward going graph

    1.44%

    Downside

    5.02%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.62
    $5.06
    downward going graph

    61.24%

    Downside

    20.93%

    Upside

    downward going graph

NRX Pharmaceuticals Inc. share price movements today

Previous Close
$4.27
Open
$4.26
Volume
813.7K
Day's Low - High
$4.12 - $4.39
52 Week Low - High
$1.62 - $5.06

NRX Pharmaceuticals Inc. Historical Returns

1 Month Return
+ 7.56 %
3 Month Return
+ 44.75 %
1 Year Return
+ 43.29 %
3 Year Return
+ 3.74 %
5 Year Return
-95.78 %

NRX Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check NRX Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$182.8M

EPS (TTM)

-0.36

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-17.1M

Revenue (TTM)

2.3M

Profit Margin

0.00%

Return On Equity TTM

-682.61%

NRX Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NRX Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NRX Pharmaceuticals Inc. image
NRX Pharmaceuticals Inc.
BUY$182.8M-95.78%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.6B515.81%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$123.3B147.44%28.8235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$70.9B15.93%16.5329.65%0.53%

Stock Returns calculator for NRX Pharmaceuticals Inc. Stock including INR - Dollar returns

The NRX Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

NRX Pharmaceuticals Inc. investment value today

Current value as on today

₹1,56,949

Returns

₹56,949

(+56.95%)

Returns from NRX Pharmaceuticals Inc. Stock

₹40,268 (+40.27%)

Dollar Impact

₹16,680 (+16.68%)

Analyst Recommendation on NRX Pharmaceuticals Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for NRX Pharmaceuticals Inc.. Average target price of $42

NRX Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on NRX Pharmaceuticals Inc..

What analysts predicted

90.05%UPSIDE

Target Price

$42

Current Price

$4.18

Analyzed by

9 Analysts

Target

$42.00

NRX Pharmaceuticals Inc. target price $42, a slight upside of 90.05% compared to current price of $4.18. According to 9 analysts rating.

Indian Investors' Interest in NRX Pharmaceuticals Inc. Stock

Search interest for NRX Pharmaceuticals Inc. Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-32% versus previous 30 day period

NRX Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
-
-
0
0
-
0
0
1
Gross Profit
0
0
0
0
0
0
-
0
0
0
Operating Income
-4
-5
-7
-3
-3
-3
-3
-4
-4
-4
EBITDA
-4
-6
-7
-1
-9
-5
-17
-5
1
-1
Interest Expense
0
0
0
-
-
-
-
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-6
-7
-1
-9
-5
-17
-5
0
-1
Income Tax Expense
-1
0
-
-
-
-
-
-
-
-
Net Income
-4
-6
-7
-1
-9
-5
-17
-5
0
-1
Net Profit Margin
-54150.00%
-81600.00%
0.00%
0.00%
-226950.00%
-137800.00%
0.00%
-2433.88%
36.62%
-133.90%

NRX Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
1
Gross Profit
0
0
0
0
0
0
Operating Income
-22
-95
-44
-27
-19
-16
EBITDA
-51
-93
-39
-30
-24
-27
Interest Expense
0
0
4
0
1
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-51
-93
-39
-30
-25
-28
Income Tax Expense
-39
-21
-4
0
-
-
Net Income
-51
-93
-39
-30
-25
-28
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-2336.49%

NRX Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-6
-7
-1
-9
-5
-17
-5
0
-1
Operating Cash Flow
-3
-3
-2
-2
-3
-4
-2
-3
-4
Investing Cash Flow
0
-
-
-
-
-
-2
0
0
Financing Cash Flow
0
4
2
1
7
1
9
4
3
Change in Cash
-3
0
0
0
4
-2
4
0
-1

NRX Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
-51
-93
-39
-30
-25
-28
Operating Cash Flow
0
0
-2
-37
-39
-21
-10
-14
Investing Cash Flow
0
40
0
0
0
0
-
-2
Financing Cash Flow
0
-39
3
63
32
6
7
23
Change in Cash
0
0
0
25
-7
-15
-3
6

Global Institutional Holdings in NRX Pharmaceuticals Inc.

Funds
Holdings
XTX Topco Ltd
0.18%
Commonwealth Equity Services Inc
1.1%
Global Retirement Partners, LLC.
0.09%
AXQ CAPITAL LP
0.08%
Advisor Group Holdings, Inc.
0%
See all

NRX Pharmaceuticals Inc. News & Key Events

  • img

    Today's Timeline - 02 December

    Tue, 07:01 PM

    -

    NRx Pharmaceuticals announces FDA receipt of ANDA for KETAFREE™, a preservative-free IV ketamine formulation.

Insights on NRX Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NRXP stock has moved up by 33.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 594.1% return, outperforming this stock by 588.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 386.1% return, outperforming this stock by 340.9%

About NRX Pharmaceuticals Inc.

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.
OrganisationNRX Pharmaceuticals Inc.
Headquarters1201 N. Market Street, Wilmington, DE, United States, 19801
IndustryBiotechnology
CEODr. Jonathan C. Javitt M.D., M.P.H.
E-voting on sharesClick here to vote

Key Management of NRX Pharmaceuticals Inc.

Name

Title

Mr. Joseph M. Casper

Chief Operating Officer

Dr. Riccardo Panicucci Ph.D.

Chief Manufacturing & Technology Officer

Dr. Hervé Perron HDR, Ph.D.

Chief Scientist

Suzanne Messere

Investor Relations

Dr. Jonathan C. Javitt M.D., M.P.H.

Co-Founder, Chairman & CEO

Mr. Michael S. Abrams M.B.A.

CFO & Treasurer

FAQs

What is NRX Pharmaceuticals Inc. share price today?

NRX Pharmaceuticals Inc. share price today is $4.18 as on at the close of the market. NRX Pharmaceuticals Inc. share today touched a day high of $4.39 and a low of $4.12.

What is the 52 week high and 52 week low for NRX Pharmaceuticals Inc. share?

NRX Pharmaceuticals Inc. share touched a 52 week high of $5.06 on and a 52 week low of $1.62 on . NRX Pharmaceuticals Inc. stock price today i.e. is closed at $4.18,which is 17.31% down from its 52 week high and 158.02% up from its 52 week low.

What is NRX Pharmaceuticals Inc.'s market capitalisation today?

NRX Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in NRX Pharmaceuticals Inc. Stock (NRXP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NRX Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NRX Pharmaceuticals Inc. Shares that will get you 0.3589 shares as per NRX Pharmaceuticals Inc. share price of $4.18 per share as on July 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy NRX Pharmaceuticals Inc. Stock (NRXP) from India?

Indian investors can start investing in NRX Pharmaceuticals Inc. (NRXP) shares with as little as ₹96.445 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹964.45 in NRX Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on NRX Pharmaceuticals Inc. share’s latest price of $4.18 as on July 21, 2026 at 1:29 am IST, you will get 2.3923 shares of NRX Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that NRX Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

NRX Pharmaceuticals Inc. stock has given -95.78% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?